In 2015, when India’s healthcare system was still largely offline and fragmented, Prashant Tandon, along with co-founders Gaurav Agarwal and Vikas Chauhan, launched 1mg — a digital health startup with a bold mission: to make healthcare transparent, accessible, and affordable for everyone.
What began as an online pharmacy offering medicines at competitive prices soon evolved into a comprehensive digital health ecosystem — connecting users to medicines, diagnostic tests, and online doctor consultations, all through a single platform.
Today, 1mg serves over 20 million users across India and stands as one of the country’s most trusted HealthTech brands. With its user-first approach, 1mg revolutionized how Indians access healthcare — bringing medical services to smartphones and doorsteps alike.
In 2021, the company reached a major milestone when it was acquired by Tata Digital, making it a part of the Tata Group’s growing digital ecosystem. Under Tata’s ownership, 1mg strengthened its infrastructure, expanded service coverage, and integrated with Tata’s healthcare and wellness portfolio, ensuring consistency and reliability at scale.
By 2025, 1mg has achieved an annual revenue of $300 million, driven by strong demand for pharmacy, lab tests, and teleconsultations. Its telemedicine segment alone has grown by 50%, reflecting how digital healthcare adoption has accelerated across India’s urban and semi-urban regions.
1mg’s success lies in its integrated model. Users can not only order medicines online but also book diagnostic tests, consult doctors, view medical records, and even receive health reminders — all within one app. This end-to-end healthcare experience sets it apart from standalone telehealth or pharmacy players.
Behind the scenes, the platform leverages AI-driven algorithms to recommend medicines, flag drug interactions, and provide detailed medical information — empowering consumers to make informed decisions about their health. With this transparency-first approach, 1mg has built deep trust among patients and healthcare professionals alike.
Its diagnostics vertical has also emerged as a strong growth driver. Partnering with accredited labs nationwide, 1mg offers home sample collection, real-time tracking, and digital reports — ensuring accuracy, speed, and convenience.
The teleconsultation feature, meanwhile, bridges the gap between patients and doctors, especially in smaller towns where access to specialists remains limited. By enabling video consultations with certified practitioners across disciplines, 1mg has democratized access to quality medical advice.
With Tata’s backing, 1mg has also invested heavily in supply-chain technology, ensuring faster deliveries, better cold-chain management for sensitive medicines, and secure prescription verification. Additionally, it has rolled out wellness products, chronic-care management programs, and subscription-based health plans, strengthening its recurring revenue model.
Yet, challenges remain. The Indian digital health space is becoming increasingly competitive, with players like PharmEasy, NetMeds, and Apollo 24|7 vying for market share. Regulatory compliance, data security, and affordability are key areas of focus. However, 1mg’s scale, trust factor, and integration under Tata Digital give it a distinct advantage.
Looking ahead, 1mg’s mission goes beyond convenience — it aims to build India’s most comprehensive digital healthcare network, seamlessly linking patients, doctors, pharmacies, and diagnostics. With the growing acceptance of online consultations and the need for affordable, transparent healthcare, the company is well-positioned to lead India’s next wave of HealthTech innovation.
From simplifying prescriptions to powering preventive care, 1mg’s journey underlines a vital shift — from treatment to total wellness. And in doing so, it’s redefining how India stays healthy in the digital age.
About The Author
